CoChat

HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients

Binder, E.B., Künzel, H.E., Nickel, T., Kern, N., Pfennig, A., Majer, M., Uhr, M., Ising, M., Holsboer, F. · 2009 · Psychoneuroendocrinology
Cited by 99

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.psyneuen.2008.08.018

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 47

  1. Aihara, 2007, HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions, Psychiatry Res., 155, 245, 10.1016/j.pscychresns.2006.11.002 · DOI · Paper page
  2. Bao, 2005, Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders, Brain, 128, 1301, 10.1093/brain/awh448 · DOI · Paper page
  3. Dawood, 2005, Glucocorticoid responses to stress in castrate and testosterone-replaced rams, Regul. Pept., 125, 47, 10.1016/j.regpep.2004.07.030 · DOI
  4. de Kloet, 2005, Stress and the brain: from adaptation to disease, Nat. Rev. Neurosci., 6, 463, 10.1038/nrn1683 · DOI · Paper page
  5. Hamilton, 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
  6. Heim, 2008, The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma, Biol. Psychiatry, 63, 398, 10.1016/j.biopsych.2007.07.002 · DOI · Paper page
  7. Heuser, 1994, Age-associated changes of pituitary–adrenocortical hormone regulation in humans: importance of gender, Neurobiol. Aging, 15, 227, 10.1016/0197-4580(94)90117-1 · DOI · Paper page
  8. Heuser, 1996, Pituitary–adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects, Am. J. Psychiatry, 153, 93, 10.1176/ajp.153.1.93 · DOI · Paper page
  9. Holsboer, 2000, The corticosteroid receptor hypothesis of depression, Neuropsychopharmacology, 23, 477, 10.1016/S0893-133X(00)00159-7 · DOI · Paper page
  10. Ising, 2005, The combined dexamethasone/CRH test as a potential surrogate marker in depression, Prog. Neuropsychopharmacol. Biol. Psychiatry, 29, 1085, 10.1016/j.pnpbp.2005.03.014 · DOI · Paper page
  11. Keck, 2003, The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats, Pharmacopsychiatry, 36, 27, 10.1055/s-2003-38092 · DOI
  12. Keck, 2002, Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders, Neuropsychopharmacology, 26, 94, 10.1016/S0893-133X(01)00351-7 · DOI · Paper page
  13. Kessler, 2003, The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R), JAMA, 289, 3095, 10.1001/jama.289.23.3095 · DOI · Paper page
  14. Kessler, 2005, Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication, Arch. Gen. Psychiatry, 62, 593, 10.1001/archpsyc.62.6.593 · DOI · Paper page
  15. Kirschbaum, 1996, Short-term estradiol treatment enhances pituitary–adrenal axis and sympathetic responses to psychosocial stress in healthy young men, J. Clin. Endocrinol. Metab., 81, 3639
  16. Komesaroff, 1998, Effects of estrogen and estrous cycle on glucocorticoid and catecholamine responses to stress in sheep, Am. J. Physiol., 275, E671
  17. Komesaroff, 1999, Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women, J. Clin. Endocrinol. Metab., 84, 606
  18. Kunzel, 2003, Pharmacological and nonpharmacological factors influencing hypothalamic–pituitary–adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex–CRH test, Neuropsychopharmacology, 28, 2169, 10.1038/sj.npp.1300280 · DOI · Paper page
  19. Laakmann, 2003, Influence of mirtazapine on salivary cortisol in depressed patients, Neuropsychobiology, 47, 31, 10.1159/000068873 · DOI
  20. Merali, 2006, Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects, Biol. Psychiatry, 59, 594, 10.1016/j.biopsych.2005.08.008 · DOI
  21. Nemeroff, 1996, The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions, Mol. Psychiatry, 1, 336
  22. Nemeroff, 1988, Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims, Arch. Gen. Psychiatry, 45, 577, 10.1001/archpsyc.1988.01800300075009 · DOI · Paper page
  23. Owashi, 2008, Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression, Psychoneuroendocrinology, 33, 152, 10.1016/j.psyneuen.2007.10.011 · DOI
  24. Redei, 1994, Fast glucocorticoid feedback inhibition of ACTH secretion in the ovariectomized rat: effect of chronic estrogen and progesterone, Neuroendocrinology, 60, 113, 10.1159/000126741 · DOI · Paper page
  25. Reul, 1994, Hypothalamic–pituitary–adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide, Neuroendocrinology, 60, 509, 10.1159/000126788 · DOI · Paper page
  26. Reul, 1993, Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic–pituitary–adrenocortical system, Endocrinology, 133, 312, 10.1210/endo.133.1.8391426 · doi:10.1210/endo.133.1.8391426 · Paper page
  27. Roca, 2005, Sex-related differences in stimulated hypothalamic–pituitary–adrenal axis during induced gonadal suppression, J. Clin. Endocrinol. Metab., 90, 4224, 10.1210/jc.2004-2525 · DOI · Paper page
  28. Rousseau, 1972, Glucocorticoid receptors: relations between steroid binding and biological effects, J. Mol. Biol., 67, 99, 10.1016/0022-2836(72)90389-0 · DOI · Paper page
  29. Scammell, 2001, Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates, Gen. Comp. Endocrinol., 124, 152, 10.1006/gcen.2001.7696 · DOI · Paper page
  30. Schmidt, 2004, The effects of pharmacologically induced hypogonadism on mood in healthy men, Arch. Gen. Psychiatry, 61, 997, 10.1001/archpsyc.61.10.997 · DOI · Paper page
  31. Schule, 2003, Attenuation of hypothalamic–pituitary–adrenocortical hyperactivity in depressed patients by mirtazapine, Psychopharmacology (Berl), 166, 271, 10.1007/s00213-002-1356-z · DOI
  32. Su, 1993, Neuropsychiatric effects of anabolic steroids in male normal volunteers, JAMA, 269, 2760, 10.1001/jama.1993.03500210060032 · DOI · Paper page
  33. Svec, 1988, Differences in the interaction of RU 486 and ketoconazole with the second binding site of the glucocorticoid receptor, Endocrinology, 123, 1902, 10.1210/endo-123-4-1902 · DOI
  34. T’Sjoen, 2005, Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men, J. Am. Geriatr. Soc., 53, 636, 10.1111/j.1532-5415.2005.53212.x · DOI · Paper page
  35. Viau, 1999, Independent and overlapping effects of corticosterone and testosterone on corticotropin-releasing hormone and arginine vasopressin mRNA expression in the paraventricular nucleus of the hypothalamus and stress-induced adrenocorticotropic hormone release, J. Neurosci., 19, 6684, 10.1523/JNEUROSCI.19-15-06684.1999 · DOI · Paper page
  36. Viau, 1996, The inhibitory effect of testosterone on hypothalamic–pituitary–adrenal responses to stress is mediated by the medial preoptic area, J. Neurosci., 16, 1866, 10.1523/JNEUROSCI.16-05-01866.1996 · DOI · Paper page
  37. Viau, 2001, Androgens alter corticotropin releasing hormone and arginine vasopressin mRNA within forebrain sites known to regulate activity in the hypothalamic–pituitary–adrenal axis, J. Neuroendocrinol., 13, 442, 10.1046/j.1365-2826.2001.00653.x · DOI · Paper page
  38. von Bardeleben, 1985, Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects, Life Sci., 37, 1613, 10.1016/0024-3205(85)90480-1 · DOI
  39. Young, 1996, Sex differences in response to exogenous corticosterone: a rat model of hypercortisolemia, Mol. Psychiatry, 1, 313
  40. Young, 2004, Puberty, ovarian steroids, and stress, Ann. N.Y. Acad. Sci., 1021, 124, 10.1196/annals.1308.013 · DOI · Paper page
  41. Young, 2001, Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats, Neuropsychopharmacology, 25, 881, 10.1016/S0893-133X(01)00301-3 · DOI · Paper page
  42. Young, 2006, Sex differences in the ACTH response to 24H metyrapone in depression, Brain Res., 1126, 148, 10.1016/j.brainres.2006.05.053 · DOI
  43. Young, 2007, Sex differences in ACTH pulsatility following metyrapone blockade in patients with major depression, Psychoneuroendocrinology, 32, 503, 10.1016/j.psyneuen.2007.03.003 · DOI
  44. Yuuki, 2005, HPA axis normalization, estimated by DEX/CRH test, but less alteration on cerebral glucose metabolism in depressed patients receiving ECT after medication treatment failures, Acta Psychiatr. Scand., 112, 257, 10.1111/j.1600-0447.2005.00625.x · DOI · Paper page
  45. Zobel, 1999, Prediction of medium-term outcome by cortisol response to the combined dexamethasone–CRH test in patients with remitted depression, Am. J. Psychiatry, 156, 949, 10.1176/ajp.156.6.949 · DOI · Paper page
  46. Zubenko, 2002, Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early onset, major depression, Am. J. Med. Genet., 114, 980, 10.1002/ajmg.b.10933 · DOI · Paper page
  47. Zubenko, 2003, Sequence variations in CREB1 cosegregate with depressive disorders in women, Mol. Psychiatry, 8, 611, 10.1038/sj.mp.4001354 · DOI

Cited by

See all 99

Metadata

Authors
Binder, E. B., Künzel, H. E., Nickel, T., Kern, N., Pfennig, A., Majer, M., Uhr, M., Ising, M., & Holsboer, F.
Venue
Psychoneuroendocrinology
Publisher
Elsevier BV
Published
2009-01
Volume
34
Issue
1
Pages
99-109
ISSN
0306-4530
Cited by
99
References
32
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients. https://app.cochat.ai/papers/10.1016/j.psyneuen.2008.08.018
The paper
Binder, E. B., Künzel, H. E., Nickel, T., Kern, N., Pfennig, A., Majer, M., Uhr, M., Ising, M., & Holsboer, F. (2009). HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients. Psychoneuroendocrinology. https://doi.org/10.1016/j.psyneuen.2008.08.018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.